SL-01

CAT: 0931-T19779-01Size: 250 mgDry Ice: NoHazardous: No
CAT#:0931-T19779-01Size:250 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
CAS Number
26049-94-5
Target
Others|||DNA/RNA Synthesis|||Autophagy|||Apoptosis|||Nucleoside Antimetabolite/Analog
Related Pathways
Cell Cycle/Checkpoint|||Others|||Apoptosis|||Autophagy|||DNA Damage/DNA Repair
Bioactivity
SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.
Smiles
ClCC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1
Molecular Formula
C18H18ClNO3
Molecular Weight
331.79
Shipping Conditions
Cool pack
Storage Temperature
-20°C

Related Products

CatalogName
T204459-01SL-164
T206776-01SL-176
T28800-01SL-870495
T209876-01SL-IN-1
T28799SL-651498
T34657SL-017
T200272-01SL agonist 1
T16896-01SL 0101-1
T209495-01SL antagonist 1
T28798-01SL-25.1188

Alternative Products

CatalogName
MBS808047-01SL-01
TRC-S560010-250MGSL 01
SIH-343-50MGZPCK (SL-01)
TBI1326-50MGSL-01, p53/mdm2 inhibitor
312071M6-01-7593-SL Pre-sized Labels for Printers
MBS6084808-01SL-01, p53/MDM2 Inhibitor (N-Benzyloxycarbonyl-Lphenylalaninylchloromethyl ketone, ZPCK)
474187SL 327
530220SL-651498
C07486SL-327
HY-106972SL-251131

Popular Products